ClinicalTrials.Veeva

Menu

Establishment and Validation of a Clinical Predictive Model for Gastrointestinal Cancer Screening Based on Patient-related Risk Factors

A

Air Force Military Medical University of People's Liberation Army

Status

Enrolling

Conditions

Risk Factors
Malignant Tumor of Digestive Tract

Study type

Observational

Funder types

Other

Identifiers

NCT06118437
XJLL-KY-20232231

Details and patient eligibility

About

Gastrointestinal tumors (esophageal cancer, gastric cancer, colorectal cancer) seriously threaten human health, with a high incidence rate and cancer related hope mortality. Digestive endoscopy is the main method for screening gastrointestinal tumors. Early screening of gastrointestinal tumors can improve the detection of early cancer and improve prognosis. The five-year survival rate of early stage tumors after comprehensive treatment can reach 90%, while the five-year survival rate of late stage tumors is less than 30%. Therefore, the screening of gastrointestinal tumors is very important.

Studies have shown that there are similarities in risk factors for gastrointestinal tumors, such as age, gender, family history, smoking, alcohol consumption, etc. Currently, established digestive malignancies are targeted at a single malignant tumor. At present, there is a lack of understanding of the overall risk factors associated with gastrointestinal tumors and the establishment of relevant risk prediction models.

Therefore, we conducted a prospective, multicenter cross-sectional study to explore the independent risk factors of combined gastrointestinal tumors and establish a risk prediction model for combined screening of gastrointestinal tumors.

Enrollment

1,550 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals aged 18-80;
  • Undergoing both gastroscopy and colonoscopy simultaneously.

Exclusion criteria

  • History of esophageal, gastric, or colorectal cancer;
  • Suspicions of gastrointestinal obstruction or perforation;
  • History of gastrointestinal tract surgery;
  • Not suitable for endoscopic examination due to serious diseases or unstable hemodynamics;
  • Unavailable relevant information;
  • Pregnancy or lactation period;
  • Unavailable informed consent form.

Trial contacts and locations

1

Loading...

Central trial contact

Yang lin Pan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems